1. Academic Validation
  2. HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration

HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration

  • Neurology. 2002 Jun 11;58(11):1673-4. doi: 10.1212/wnl.58.11.1673.
K H L Ching 1 S K Westaway J Gitschier J J Higgins S J Hayflick
Affiliations

Affiliation

  • 1 Department of Molecular and Medical Genetics, School of Medicine, Oregon Health and Science University, Portland, OR 97201, USA.
Abstract

HARP (hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration) is a rare syndrome with many clinical similarities to pantothenate kinase-associated neurodegeneration (PKAN, formerly Hallervorden-Spatz syndrome). Despite these common features, lipoprotein abnormalities have not been reported in PKAN. After the recent discovery of the genetic defect in PKAN, we report a homozygous nonsense mutation in exon 5 of the PANK2 gene that creates a stop codon at amino acid 371 (R371X) in the original HARP patient. This finding establishes that HARP is part of the PKAN disease spectrum.

Figures